VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 45,200 Baxter International Inc. $BAX

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Baxter International Inc. (NYSE:BAX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 45,200 shares of the medical instruments supplier's stock, valued at approximately $964,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Baxter International during the 2nd quarter worth approximately $1,744,874,000. Pzena Investment Management LLC acquired a new position in Baxter International during the second quarter valued at approximately $1,392,098,000. Geode Capital Management LLC raised its position in Baxter International by 7.8% during the fourth quarter. Geode Capital Management LLC now owns 13,510,205 shares of the medical instruments supplier's stock valued at $257,174,000 after purchasing an additional 972,891 shares in the last quarter. California State Teachers Retirement System lifted its stake in Baxter International by 2,009.1% during the second quarter. California State Teachers Retirement System now owns 12,720,343 shares of the medical instruments supplier's stock worth $271,198,000 after purchasing an additional 12,117,222 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Baxter International by 1.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 7,638,629 shares of the medical instruments supplier's stock valued at $231,304,000 after purchasing an additional 97,687 shares in the last quarter. Institutional investors own 90.19% of the company's stock.

Baxter International Stock Up 0.0%

Shares of NYSE:BAX opened at $23.80 on Monday. Baxter International Inc. has a 52-week low of $15.73 and a 52-week high of $30.00. The company has a market capitalization of $12.31 billion, a PE ratio of -11.50, a price-to-earnings-growth ratio of 3.60 and a beta of 0.60. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The company has a fifty day moving average of $24.98 and a 200-day moving average of $20.84.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The business had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same quarter in the previous year, the company posted $0.59 EPS. Baxter International's quarterly revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities analysts predict that Baxter International Inc. will post 2.04 EPS for the current fiscal year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th. Baxter International's dividend payout ratio (DPR) is presently -1.93%.

Wall Street Analysts Forecast Growth

BAX has been the topic of several recent analyst reports. Wall Street Zen upgraded Baxter International from a "hold" rating to a "buy" rating in a research note on Saturday, August 1st. Zacks Research upgraded Baxter International from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 11th. The Goldman Sachs Group raised their price objective on Baxter International from $19.00 to $21.00 and gave the company a "neutral" rating in a research note on Wednesday, July 15th. Weiss Ratings upgraded Baxter International from a "sell (d-)" rating to a "sell (d)" rating in a research report on Friday, July 31st. Finally, Stifel Nicolaus boosted their target price on Baxter International from $19.00 to $24.00 and gave the stock a "hold" rating in a research note on Tuesday, July 28th. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Baxter International presently has an average rating of "Hold" and an average price target of $22.45.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops and supplies medical products and technologies used in hospitals, outpatient facilities, physician offices and other care settings. Its offerings include intravenous therapy products and infusion systems, injectable medications and drug-compounding technologies, surgical products, patient-monitoring systems, respiratory-care equipment, and products used in hospital beds and connected-care environments.

The company serves healthcare providers and patients in numerous countries, with operations and customers across North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.